Physician profile
Robert Jay Landy
NPI 1093715633
$917.72
in general payments reported to CMS, 2019-2025
11 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $468 · 2020: $72.80 · 2021: $19.95 · 2023: $22.01 · 2024: $201 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $238.46 | 2019 | |
| Medtronic Vascular, INC. | $192.81 | 2019-2020 | |
| Nevro Corp. | $180.28 | 2024 | Senza |
| Amgen INC. | $122.19 | 2025 | Krystexxa |
| Stryker Corporation | $35.85 | 2019 | |
| Paratek Pharmaceuticals, INC. | $33.07 | 2020 | |
| Orthofix Medical, INC. | $33.02 | 2019-2025 | Physio-Stim |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.01 | 2023 | Jublia |
| Acumed LLC | $20.31 | 2024 | Osteomed |
| Alfasigma USA, INC. | $19.95 | 2021 | |
| Integra Lifesciences Corporation | $19.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Landy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.